Impact of preoperative antithrombotic therapy in patients undergoing elective isolated coronary artery bypass grafting.
Gijs G J van SteenbergenAlbert H M van StratenSerhat KabakDennis van VeghelLukas DekkerMohamed A Soliman-HamadPublished in: Interactive cardiovascular and thoracic surgery (2021)
Preoperative use of AT therapy other than ASA monotherapy in patients who elected CABG was associated with the increased postoperative use of blood products and risk of re-exploration for bleeding; this finding was even more pronounced in non-guideline-adherent patients.
Keyphrases
- patients undergoing
- coronary artery bypass grafting
- end stage renal disease
- coronary artery disease
- percutaneous coronary intervention
- atrial fibrillation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- open label
- randomized controlled trial
- acute coronary syndrome
- combination therapy
- patient reported